Cefuroxime News
Orchid receives US FDA approval for Cefuroxime Axetil ANDA
Orchid Chemicals & Pharmaceuticals Ltd on February 20, 2008 has announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets. The product is available in...
Ranbaxy Receives USFDA Approval For Cefuroxime Axetil
India’s biggest pharma company, Ranbaxy Laboratories Ltd has announced that it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Cefuroxime Axetil for Oral Suspension USP, 125...
Orbus granted European patent for its cefuroxime axetil product compositions
Orbus Pharma Inc. (ORB - TSX), ("Orbus"), today announced that the European Patent Office has granted a patent to Orbus for its Cefuroxime Axetil product compositions. The patent covers a unique fast release formulation which...
Experts debate pros and cons of intracameral cefuroxime
Concerns about the unavailability of cefuroxime in single sterile doses for intracameral injection are the main reasons why American cataract surgeons do not use this antibiotic for prevention of postoperative endophthalmitis,...
ORBUS recieves approval and first purchase order for cefuroxime axetil in Spain
Orbus Pharma Inc., today announces it has received regulatory approval for sale in Spain of the company's generic version of Cefuroxime Axetil Tablets, in 250 mg and 500 mg dosage form.